uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Growth factor-antagonized rexinoid apoptosis involves permissive PPARgamma/RXR heterodimers to activate the intrinsic death pathway by NO.
Show others and affiliations
2009 (English)In: Cancer Cell, ISSN 1535-6108, E-ISSN 1878-3686, Vol. 16, no 3, 220-31 p.Article in journal (Refereed) Published
Abstract [en]

Growth factor (GF) deprivation and/or blocking of cognate signaling can induce apoptosis and is the basis of several cancer treatment paradigms. We observed that RXR agonists (rexinoids) induce apoptosis of tumor cells when GF support is abrogated. This "rexinoid apoptosis" involves activation of both iNOS and eNOS by RXR-PPARgamma and results in production of apoptogenic NO. IGF/EGF-induced IGF receptor 1-mediated MAP kinase blocks rexinoid apoptosis by RXR phosphorylation. Combining rexinoids with the MAPK inhibitor U0126 induced apoptosis in human cancer cells in vitro and ex vivo and blocked xenograft growth in vivo. Our results suggest a regulatory mechanism in which GF signaling antagonizes RXR-PPARgamma-mediated default apoptosis to sustain cell life.

Place, publisher, year, edition, pages
2009. Vol. 16, no 3, 220-31 p.
URN: urn:nbn:se:uu:diva-133800DOI: 10.1016/j.ccr.2009.07.029PubMedID: 19732722OAI: oai:DiVA.org:uu-133800DiVA: diva2:370394
Available from: 2010-11-16 Created: 2010-11-16 Last updated: 2010-11-16

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed
In the same journal
Cancer Cell

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 137 hits
ReferencesLink to record
Permanent link

Direct link